Shah Rajeev M.
Transactions
50
Companies
57
Filings
6
CIK
0001619841
Recent Transactions
- Disposition to Issuer
- Disposition to Issuer
- Exercise/Conversion
- Exercise/Conversion
- Disposition to Issuer
- Disposition to Issuer
- Purchase
- Award
- Award
- Purchase
- Award
- Purchase
- Disposition to Issuer
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
Companies
57- $FDMT
4D Molecular Therapeutics, Inc.
10% Owner
- $ETNB
89bio, Inc.
Director, 10% Owner
- $ACRV
Acrivon Therapeutics, Inc.
Director, 10% Owner
- $ABOS
Acumen Pharmaceuticals, Inc.
Director, 10% Owner
Akouos, Inc.
10% Owner
- $ANTX
AN2 Therapeutics, Inc.
10% Owner
- $SPRY
ARS Pharmaceuticals, Inc.
Director, 10% Owner
- $ARTV
Artiva Biotherapeutics, Inc.
Director, 10% Owner
- $BCAX
Bicara Therapeutics Inc.
Director, 10% Owner
- $BDTX
Black Diamond Therapeutics, Inc.
Director
- $BOLD
Boundless Bio, Inc.
10% Owner
- $CRDF
Cardiff Oncology, Inc.
10% Owner
- $CDTX
Cidara Therapeutics, Inc.
Director, 10% Owner
- $CLYM
Climb Bio, Inc.
Director, 10% Owner
- $CTKB
Cytek Biosciences, Inc.
Director
DICE Therapeutics, Inc.
Director, 10% Owner
- $DYN
Dyne Therapeutics, Inc.
10% Owner
Eidos Therapeutics, Inc.
Director
- $ELVN
Enliven Therapeutics, Inc.
10% Owner
- $EVMN
Evommune, Inc.
Director, 10% Owner
Forma Therapeutics Holdings, Inc.
10% Owner
- $FULC
Fulcrum Therapeutics, Inc.
10% Owner
Icosavax, Inc.
Director, 10% Owner
Inhibrx, Inc.
10% Owner
Inozyme Pharma, Inc.
10% Owner
iTeos Therapeutics, Inc.
10% Owner
- $ITRM
Iterum Therapeutics plc
10% Owner
- $JBIO
Jade Biosciences, Inc.
10% Owner
- $JANX
Janux Therapeutics, Inc.
Director, 10% Owner
- $KALA
KALA BIO, Inc.
Director, 10% Owner
- $KALV
KalVista Pharmaceuticals, Inc.
Director
- $LENZ
LENZ Therapeutics, Inc.
Director, 10% Owner
- $MLYS
Mineralys Therapeutics, Inc.
Director
- $NKTX
Nkarta, Inc.
Director, 10% Owner
Orchard Therapeutics plc
10% Owner
Pandion Therapeutics, Inc.
10% Owner
- $PEPG
PepGen Inc.
Director, 10% Owner
- $PHAT
Phathom Pharmaceuticals, Inc.
10% Owner
- $PMVP
PMV Pharmaceuticals, Inc.
10% Owner
POINT Biopharma Global Inc.
Director
Ra Pharmaceuticals, Inc.
Director
- $RYTM
RHYTHM PHARMACEUTICALS, INC.
10% Owner
- $RXST
RxSight, Inc.
10% Owner
Satsuma Pharmaceuticals, Inc.
Director, 10% Owner
- $SCPH
scPharmaceuticals Inc.
10% Owner
- $SEPN
Septerna, Inc.
Director, 10% Owner
- $SION
Sionna Therapeutics, Inc.
Director, 10% Owner
- $SLDB
Solid Biosciences Inc.
10% Owner
Synthorx, Inc.
10% Owner
- $TGTX
TG THERAPEUTICS, INC.
10% Owner
- $TYRA
Tyra Biosciences, Inc.
Director, 10% Owner
- $PCVX
Vaxcyte, Inc.
10% Owner
- $VSTM
Verastem, Inc.
10% Owner
- $VRDN
Viridian Therapeutics, Inc.\DE
10% Owner
- $VOR
Vor Biopharma Inc.
Director, 10% Owner
- $WVE
Wave Life Sciences Ltd.
Director, 10% Owner
- $HOWL
Werewolf Therapeutics, Inc.
Director, 10% Owner
Recent Filings
6Address
C/O RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA, 02116